发明名称 Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate
摘要 The invention relates to the novel salts AB of the base A with a physiologically acceptable acid B which is selected from the group consisting of hydrochloric acid, hydrobromic acid, sulfuric acid, fumaric acid and salicylic acid and the polymorphic compounds, the corresponding solvates and hydrates thereof.
申请公布号 US8551987(B2) 申请公布日期 2013.10.08
申请号 US20080680060 申请日期 2008.09.25
申请人 PACHUR KATHRIN;RIES UWE JOERG;WERTHMANN ULRIKE;SPROLL SONJA;BOEHRINGER INGELHEIM INTERNATIONAL GMBH 发明人 PACHUR KATHRIN;RIES UWE JOERG;WERTHMANN ULRIKE;SPROLL SONJA
分类号 C07D401/14;A61K31/551 主分类号 C07D401/14
代理机构 代理人
主权项
地址